DPP4 INHIBITORS Janumet 50 mg-1,000 mg tablet Januvia 50 mg tablet Janumet 50 mg-500 mg tablet Onglyza 2.5 mg tablet Januvia 100 mg tablet Onglyza 5 mg tablet Januvia 25 mg tablet Tradjenta 5 mg tablet For new starts only, claims will process for Januvia, Janumet, Onglyza, or Tradjenta if a claim for metformin has been processed in the past 120 days. 1
FLUVASTATIN fluvastatin 20 mg capsule fluvastatin ER 80 mg tablet,extended fluvastatin 40 mg capsule release 24 hr For new starts only, claims for fluvastatin will process if a claim for simvastatin, atorvastatin, or rosuvastatin is processed in the past 120 days. 2
GLP-1 AGONISTS Bydureon 2 mg/0.65 ml subcutaneous Trulicity 0.75 mg/0.5 ml subcutaneous pen injector pen injector Bydureon BCise 2 mg/0.85 ml Trulicity 1.5 mg/0.5 ml subcutaneous pen subcutaneous auto-injector injector Byetta 10 mcg/dose(250 mcg/ml)2.4 ml Victoza 3-Pak 0.6 mg/0.1 ml (18 mg/3 subcutaneous pen injector ml) subcutaneous pen injector Byetta 5 mcg/dose (250 mcg/ml)1.2 ml subcutaneous pen injector For new starts only, claims will process for Victoza, Trulicity, Bydureon, or Byetta if a claim for metformin has been processed in the past 120 days. 3
MYRBETRIQ Myrbetriq 25 mg tablet,extended release Myrbetriq 50 mg tablet,extended release For new starts only, claims will process for Myrbetriq if a claim for oxybutynin, tolterodine, or trospium has been processed in the past 120 days. 4
RASAGILINE rasagiline 0.5 mg tablet rasagiline 1 mg tablet For new starts only, claims will process for rasagiline if a claim for selegeline has been processed in the past 120 days. 5
SGLT2 INHIBITORS Invokana 100 mg tablet Synjardy XR 10 mg-1,000 mg tablet, Invokana 300 mg tablet extended release Jardiance 10 mg tablet Synjardy XR 12.5 mg-1,000 mg tablet, Jardiance 25 mg tablet extended release Synjardy 12.5 mg-1,000 mg tablet Synjardy XR 25 mg-1,000 mg tablet, Synjardy 12.5 mg-500 mg tablet extended release Synjardy 5 mg-1,000 mg tablet Synjardy XR 5 mg-1,000 mg tablet, Synjardy 5 mg-500 mg tablet extended release For new starts only, claims will process for Invokana, Jardiance, or Synjardy, if a claim for metformin has processed in the past 120 days. 6
TYMLOS Tymlos 80 mcg/dose (3,120 mcg/1.56 ml) subcutaneous pen injector FOR NEW STARTS ONLY, CLAIMS FOR FORTEO WILL PROCESS IF A CLAIM FOR ALENDRONATE, RISEDRONATE, OR IBANDRONATE ARE PROCESSED IN THE PAST 120 DAYS. 7
ULORIC Uloric 40 mg tablet Uloric 80 mg tablet FOR NEW STARTS ONLY, CLAIMS FOR ULORIC WILL PROCESS IF A CLAIM FOR ALLOPURINOL 300 MG PER DAY IS PROCESSED IN THE PAST 120 DAYS. 8
Index B Bydureon 2 mg/0.65 ml subcutaneous pen injector... 3 Bydureon BCise 2 mg/0.85 ml subcutaneous auto-injector... 3 Byetta 10 mcg/dose(250 mcg/ml)2.4 ml subcutaneous pen injector... 3 Byetta 5 mcg/dose (250 mcg/ml)1.2 ml subcutaneous pen injector... 3 F fluvastatin 20 mg capsule... 2 fluvastatin 40 mg capsule... 2 fluvastatin ER 80 mg tablet,extended release 24 hr... 2 I Invokana 100 mg tablet... 6 Invokana 300 mg tablet... 6 J Janumet 50 mg-1,000 mg tablet... 1 Janumet 50 mg-500 mg tablet... 1 Januvia 100 mg tablet... 1 Januvia 25 mg tablet... 1 Januvia 50 mg tablet... 1 Jardiance 10 mg tablet... 6 Jardiance 25 mg tablet... 6 M Myrbetriq 25 mg tablet,extended release... 4 Myrbetriq 50 mg tablet,extended release... 4 O Onglyza 2.5 mg tablet... 1 Onglyza 5 mg tablet... 1 R rasagiline 0.5 mg tablet... 5 rasagiline 1 mg tablet... 5 S Synjardy 12.5 mg-1,000 mg tablet... 6 Synjardy 12.5 mg-500 mg tablet... 6 Synjardy 5 mg-1,000 mg tablet... 6 Synjardy 5 mg-500 mg tablet... 6 Synjardy XR 10 mg-1,000 mg tablet, extended release... 6 Synjardy XR 12.5 mg-1,000 mg tablet, extended release... 6 Synjardy XR 25 mg-1,000 mg tablet, extended release... 6 Synjardy XR 5 mg-1,000 mg tablet, extended release... 6 T Tradjenta 5 mg tablet... 1 Trulicity 0.75 mg/0.5 ml subcutaneous pen injector... 3 Trulicity 1.5 mg/0.5 ml subcutaneous pen injector... 3 Tymlos 80 mcg/dose (3,120 mcg/1.56 ml) subcutaneous pen injector... 7 U Uloric 40 mg tablet... 8 Uloric 80 mg tablet... 8 V Victoza 3-Pak 0.6 mg/0.1 ml (18 mg/3 ml) subcutaneous pen injector... 3 9